The national Whole Genome Sequencing (WGS) service is now available for patients that meet the eligibility for clinical indications in rare disease and cancer.
Full details can be found on the relevant National Test Directory.
If you wish to access the Whole Genome Sequencing service for your patients the links below give more information on the required process and documentation and the support available for submitting cases for testing.
Incomplete or insufficient information, including failure to provide all required details, documentation and samples at the point of referral, may delay Whole Genome Sequencing (WGS) submission and could result in delays to the reporting of results.